Lauren Merendino, Chief Commercial Officer at Myovant Sciences Ltd. (MYOV), sold 1,703 shares at $25.20 ($43K) on 2022-10-18, disclosed to the SEC on 2022-10-20.
Open-market sale of $43k MYOV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2025-08-19 | $25K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $25K | — | Filing → |
| MYOV | SELL | 2023-01-20 | $108K | — | Filing → |